Adrenomedullin: Exciting new horizons

Recent Patents on Endocrine, Metabolic and Immune Drug Discovery

Volumn 6, Issue 1, 2012, Pages 4-17

  Cheung, Bernard M Y ^a   Tang, Fai ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adrenomedullin; Cardiovascular system; Nitric oxide; Peptide; Vasodilation

Indexed keywords

ADRENOMEDULLIN; ADRENOMEDULLIN RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; COMPLEMENT FACTOR H; GLUCOSE; INTERLEUKIN 10; INTERLEUKIN 6; INTERMEDIN;

ADIPOSE TISSUE; ANGIOGENESIS; ARTICLE; ASTHMA; BLOOD PRESSURE REGULATION; BONE GROWTH; BRONCHIECTASIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; DISEASE MARKER; DOSE RESPONSE; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; ENDOCRINE SYSTEM; ESSENTIAL HYPERTENSION; FEMALE GENITAL SYSTEM; FRACTURE; GLUCOSE TRANSPORT; HEART INFARCTION; HUMAN; IMMUNITY; IMMUNOREACTIVITY; INFECTION; INSULIN RESISTANCE; ISCHEMIA; KIDNEY DISEASE; LIPOLYSIS; MALE GENITAL SYSTEM; MUSCULOSKELETAL SYSTEM; NERVOUS SYSTEM; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RENAL SYSTEM PARAMETERS; RHEUMATOID ARTHRITIS; SEPTIC SHOCK; SIGNAL TRANSDUCTION; STROKE; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS;

EID: 84856552041     PISSN: 18722148     EISSN: None     Source Type: Journal    
DOI: 10.2174/187221412799015263     Document Type: Article

References (187)

1. Kitamura K, Kangawa K, Kawamoto M, Ichiki Y, Nakamura S, Matsuo H, et al. Adrenomedullin: A novel hypotensive peptide isolated from human phenochromocytoma. Biochem Biophys Res Commun 1993; 192: 533-560.
2. Ishimitsu T, Kojima M, Kangawa K, Hino J, Matsuoka H, Kitamura K, et al. Genomic structure of human adrenomedullin gene. Biochem Biophys Res Commun 1994; 203: 631-639.
3. Eto T. A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides 2001; 22: 1693-1711.
4. Roh J, Chang CL, Bhalla A, Klein C, Hsu SY. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activitymodifying protein receptor complexes. J Biol Chem 2004; 279(8): 7264-7274.
5. Martínez A, Julián M, Bregonzio C, Notari L, Moody TW, Cuttitta F. Identification of vasoactive nonpeptidic positive and negative modulators of adrenomedullin using a neutralizing antibody-based screening strategy. Endocrinology 2004; 145(8): 3858-3865.
6. Sakata J, Shimokubo T, Kitamura K, Nishizono M, Iehiki Y, Kangawa K, et al. Distribution and characterization of immunoreactive rat adrenomedullin in tissue and plasma. FEBS Lett 1994; 352: 105-108.
7. Hwang IS, Tang F. The distribution and gene expression of adrenomedullin in the rat brain: Peptide/mRNA and precursor/ active peptide relationships. Neurosci Lett 1999; 267(2): 85-88.
8. Hwang IS, Tang F. Peripheral distribution and gene expression of adrenomedullin in the rat: Possible source of blood adrenomedullin. Neuropeptides 2000; 34(1): 32-7.
9. Meeran K, Oshea D, Upton PD, Small CJ, Ghatei MA, Byfield PH, Bloom SR. Circulating adrenomedullin does not regulate systemic blood pressure but increases plasma prolactin after intravenous infusion in humans: A pharmacokinetic study. J Clin Endocrinol Metab 1997; 82: 95-100.
10. Kitamura, K., Kangawa, K., Matsuo, H., Eto, T. Adrenomedullin. US5910416 (1998).
11. Sugo S, Minamino N, Shoji H, Kangawa K, Kitamura K, Eto T, et al. Interleukin-1 tumor necrosis factor and lipopolysaccharide additively stimulate production of adrenomedullin in vascular smooth muscle cells. Biochem Biophys Res Commun 1995; 207: 25-32.
12. Ishimitsu T, Miyata A, Matsuoka H, Kangawa K. Transcriptional regulation of human adrenomedullin gene in vascular endothelial cells. Biochem Biophys Res Commun 1998; 243: 463-470.
13. Shindo T, Kurihara H, Kurihara Y, Morita H, Yazaki Y. Upregulation of endothelin-1 and adrenomedullin gene expression in the mouse endotoxin shock model. J Cardiovasc Pharmacol 1998; 31: S541-S544.
14. Sugo S, Minamino N, Shoji H, Kangawa K, Matsuo H. Effects of vasoactive substances and cAMP related compounds on adrenomedullin production in cultured vascular smooth muscle cells. FEBS Lett 1995; 369: 311-314.
15. Owji AA, Smith DM, Coppock HA, Morgan DGA, Bhogal R, Ghatei MA, et al. An abundant and specific binding site for the novel vasodilator adrenomedullin in the rat. Endocrinology 1995; 136: 2127-2134.
16. Nuki C, Kawasaki H, Kitamura K, Takenaga M, Kangawa K, Eto T, et al. Vasodilator effect of adrenomedullin and calcitonin generelated peptide receptors in rat mesenteric vascular beds. Biochem Biophys Res Commun 1993; 196: 245-251.
17. McLatchie LM, Fraser NJ, Main MJ, Wise A, Brown J, Thompson N, et al. RAMPs regulate the transport, and ligand specificity of the calcitonin-receptor-like receptor. Nature 1998; 393: 333-339.
18. Kuwasako K, Kitamura K, Nagata S, Hikosaka T, Takei Y, Kato J. Shared and separate functions of the RAMP-based adrenomedullin receptors. Peptides 2011; 32(7): 1540-1550.
19. Dackor R, Fritz-Six K, Smithies O, Caron K. Receptor activitymodifying proteins 2 and 3 have distinct physiological functions from embryogenesis to old age. J Biol Chem 2007; 282(25): 18094-18099.
20. Kadmiel M, Fritz-Six K, Pacharne S, Richards GO, Li M, Skerry TM, Caron KM. Research resource: Haploinsufficiency of receptor activity-modifying protein-2 (RAMP2) causes reduced fertility, hyperprolactinemia, skeletal abnormalities, and endocrine dysfunction in mice. Mol Endocrinol. 2011; 25(7): 1244-1253.
21. Hong Y, Hay DL, Quirion R, Poyner DR. The pharmacology of Adrenomedullin 2/Intermedin. Br J Pharmacol 2011; doi: 10.1111/j.1476-5381.2011.01530.x.
22. Shimekake Y, Nagata K, Ohta S, Kambayashi Y, Teraoka H, Kitamura K, et al. Adrenomedullin stimulates two signal transduction pathways, cAMP accumulation and Ca2+ mobilization, in bovine aortic endothelial cells. J Biol Chem 1995; 270: 4412-4417.
23. Wangensteen R, Quesada A, Sainz J, Duarte J, Vargas F, Osuna A. Role of endothelium-derived relaxing factors in adrenomedullininduced vasodilation in the rat kidney. Eur J Pharmacol 2002; 444: 97-102.
24. Nishimatsu H, Suzuki E, Nagata D, Moriyama N, Satonaka H, Walsh K, et al. Adrenomedullin induces endothelium-dependent vasorelaxation via the phosphatidylinositol 3-kinase/Akt-dependent pathway in rat aorta. Circ Res 2001; 89: 63-70.
25. Okumura h, Nagaya N, Itoh T, Okano I, Hino J, Mori K, et al. Adrenomedullin infusion attenuates myocardial ischemia/ reperfusion injury through the phosphatidylinositol 3- kinase/Akt dependent pathway. Circulation 2004; 109: 242-248.
26. Kim W, Moon SO, Sung MJ, Kim SH, Lee S, So JN, et al. Angiogneic role of adenomedullin through activation of Akt, mitogenactivated protein kinase, and focal adhesion kinase in endothelial cells. FASEB J 2003; 17: 1937-1939.
27. Semplicini A, Ceolotto G, Baritono E, Malenowicz LK, Andreis PG, Sartoli M, et al. Adrenomedullin stimulates DNA synthesis of rat adrenal zona glomerulosa cells through activation of the mitogen-activated kinae-dependent cascade. J Hypertens 2001; 19(3 pt 2): 599-602.
28. Pio R, Martinez A, Unsworth EJ, Kowalak JA, Bengoechea JA, Zipfel PF, et al. Complement factor H is a serum-binding protein for adrenomedullin, and the resulting complex modulates the bioactivities of both partners. J Biol Chem 2001; 276: 12292-1300.
29. Morgenthaler NG, Struck J, Alonso C, Bergmann A. Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clin Chem 2005; 51(10): 1823-1829.
30. Samson WK. Adrenomedullin and the control of fluid and electrolyte homeostasis. Annu Rev Physiol 1999; 61: 363-89.
31. Sato A, Canny BJ, Autelitano DJ. Adrenomedullin stimulates cAMP accumulation and inhibits atrial natriuretic peptide gene expression in cardiomyocytes. Biochem Biophys Res Commun 1997; 230(2): 311-314.
32. Tsuruda T, Kato J, Kitamura K, Kuwasako K, Imamura T, Koiwaya Y, et al. Adrenomedullin: A possible autocrine or paracrine inhibitor of hypertrophy of cardiomyocytes. Hypertension. 1998; 31(1 Pt 2): 505-510.
33. Tsuruda T, Kato J, Kitamura K, Kawamoto M, Kuwasako K, Imamura T, et al. An autocrine or a paracrine role of adrenomedullin in modulating cardiac fibroblast growth. Cardiovasc Res 1999; 43(4): 958-967.
34. Autelitano DJ, Ridings R, Tang F. Adrenomedullin is a regulated modulator of neonatal cardiomyocyte hypertrophy in vitro. Cardiovasc Res 2001; 51(2): 255-64.
35. Cockcroft JR, Noon JP, Gardner-Medwin J, Bennett T. Haemodynamic effects of adrenomedullin in human resistance and capacitance vessels. Br J Clin Pharmacol 1997; 44: 57-60.
36. De Matteo R, May CN. Direct coronary vasodilator action of adrenomedullin is mediated by nitric oxide. Br J Pharmacol 2003; 140(8): 1414-20.
37. Autelitano DJ, Tang F, Little PJ. Rapid regulation of adrenomedullin in metabolically compromised vascular smooth muscle cells. J Hypertens 1999; 17(3): 373-379.
38. Kano H, Kohno M, Yasunari K, Yokokawa K, Horio T, Ikeda M, Minami M, Hanehira T, Takeda T, Yoshikawa J. Adrenomedullin as a novel antiproliferative factor of vascular smooth muscle cells. J Hypertens 1996; 14: 209-213.
39. Lainchbury JG, Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormonal, and renal effects of short-term adrenomedullin infusion in healthy volunteers. J Clin Endocrinol Metab 2000; 85: 1016-1020.
40. Szokodi I, Kinnunen P, Ruskoaho H. Inotropic effect of adrenomedullin in the isolated perfused rat heart. Acta Physiol Scand 1996; 156: 151-2.
41. Ikenouchi H, Kangawa K, Matsuo H, Hirata Y. Negative inotropic effect of adrenomedullin in isolated adult rabbit cardiac ventricular myocytes. Circulation 1997; 95: 2318-2324.
42. Mukherjee R, Multani MM, Sample JA, Dowdy KB, Zellner JL, Hoover DB, et al. Effects of adrenomedullin on human myocyte contractile function and beta-adrenergic response. J Cardiovas Parmacol Ther 2002; 7: 235-40.
43. Ebara T, Miura K, Okumura M, Matsuura T, Kim S, Yukimura T, et al. Effect of adrenomedullin on renal hemodynamics and functions in dogs. Eur J Pharmacol 1994; 263: 69-73.
44. Jougasaki M, Aarhus LL, Heublein DM, Sandberg SM, Burnett JC, Jr. Role of prostaglandins and renal nerves in the renal actions of adrenomedullin. Am J Physiol 1997; 272: F260-F266.
45. Miura K, Ebara T, Okumura M, Matsuura T, Kim S, Yukimura T, et al. Attenuation of adrenomedullin-induced renal vasodilation by NG-nitro L-arginine but not glibenclamide. Br J Pharmacol 1995; 115: 917-924.
46. Man SY, Hwang IS, Li YY, O WS, Sheng HP, Tang F. Differential regulation of adrenomedullin gene expression in the fundic and pyloric regions of the rat stomach during acute and chronic starvation. Neuropeptides 2007; 41(3): 177-187.
47. Kravtsov GM, Hwang IS, Tang F. The inhibitory effect of adrenomedullin in the rat ileum: Cross-talk with beta3- adrenoceptor in the serotonin-induced muscle contraction. J Pharmacol Exp Ther 2004; 308(1): 241-248.
48. Parkes DG, May CN. ACTH-suppressive and vasodilator action of AM in conscious sheep. J Neuroendocrinol 1995; 7: 923-929.
49. Kita T, Tokashiki M, Kitamura K. Aldosterone antisecretagogue and antihypertensive actions of adrenomedullin in patients with primary aldosteronism. Hypertens Res 2010; 33(4): 374-379.
50. Jensen BL, Kramer BK, Kurtz A. Adrenomedullin stimulates renin release and renin mRNA in mouse juxtaglomerular granular cells. Hypertension 1997; 29: 1148-1155.
51. Yamaguchi T, Baba K, Doi Y, Yano K, Kitamura K, Eto T. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rats. Hypertension 1996; 28: 308-314.
52. Serrano J, Uttenthal LO, Matrinez A, Fernandez AP, Martinez de Velasco J, et al. Distribution of adrenomedullin-like immunoreactivity in the rat central nervous system by light and electron microscopy. Brain Res 2000; 853: 245-268.
53. Ueta Y, Kitamura K, Isse T, Shibuya I, Kabashima N, Yamamoto S, et al. Adrenomedullin-immunoreactive neurons in the paraventricular, and supraoptic nuclei of the rat. Neurosci Lett 1995; 202: 37-40.
54. Samson WK, Murphy TC. Adrenomedullin inhibits salt appetite. Endocrinology 1996; 138: 613-616.
55. Takahashi H, Watanabe TX, Nishimura M, Nakanishi T, Sakamoto M, Yoshimura M, et al. Centrally induced vasopressor and sympathetic responses to novel endogenous peptide, adrenomedullin, in anesthetized rats. Am J Physiol 1994; 7: 478-482.
56. Wang X, Yue TL, Barone FC, White RF, Clark RK, Willette RN, et al. Discovery adrenomedullin in rat ischemic cortex and evidence for its role in exacerbating focal brain ischemic damage. Proc Natl Acad Sci USA 1995; 92: 11480-1144.
57. Knerr I, Schirl C, Horbach T, Stuppy A, Carbon R, Rascher W, et al. Maturation of the expression of adreomedullin, endothlin-1 and nitric oxide synthases in adipose tissues from childhood to adulthood. Int J Obes (Lond) 2005; 29: 275-280.
58. Fukai N, Yoshimoto T, Sugiyama T, Ozawa N, Sato R, Shichiri M, et al. Concomitant expression of adrenomedullin and its receptor component in rat adipose tissues. Am J Physiol Endo Metab 2005; 288: E56-E62.
59. Go AD, Chow KH, Hwang IS, Tang F. Adrenomedullin and its receptor components in adipose tissues: Differences between white and brown fats and the effects of adrenergic stimulation. Peptides 2007; 28: 920-927.
60. Nambu T, Arai H, Komatsu Y, Yasoda A, Moriyama K, Kanamoto N, et al. Expression of the adrenomedullin gene in adipose tissue. Regul Pept 2005; 132: 17-22.
61. Li Y, Jiang C, Wang X, Zhang Y, Shibahara S, Takahashi K. Adrenomedullin is a novel adipokine: Adrenomedullin in adipocytes and adipose tissues. Peptides 2007; 28: 1128-1143.
62. Letzia C, Iacobellis G, Caliumi C, Leonett F, Cotesta D, Ribaudo MC, et al. hyperinsulinemia is associated with increased plasma adrenomedullin concentrations in uncomplicated obesity. Exp Clin Endocrinol Daibetes 2005; 113: 171-175.
63. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Urakawa H, Morioka K, et al. Acute hyperinsulinemia is associated with increased circulating levels of adrenomedullin in patients with type 2 diabetes mellitus. Eur J Endcorinol 2002; 147: 71-5.
64. Linshield P, Seboek D, Zulewski H, Keller U. Muller B. Autocrine/paracrine role of inflammation-mediated calcitonin gene-related peptide and adrenomedullin expression in human adipose tissue. Endocrinology 2005; 146: 2699-2708.
65. Harmancey R, Senard JM, Pathak A, Desmoulin F, Claparols C, Rouet P, et al. The vasoactive peptide adrenomedulin is secreted by adipocytes and inhibits lipolysis through NO-mediated β- adrenergic agonist oxidation. FASEB J 2005; 19: 4045-4407.
66. Miyashita K, Itoh H, Sawada N, Fuunaga Y, Sone M, Yamahara K, et al. provokes endothelial Akt activation and promotes vascular regeneration both in vitro and in vivo. FEBS Lett 2003; 544: 86-92.
67. Wong LYF, Cheung BMY, Li CYY, HY Lan, Tang F. Adrenomedullin modulates MIF secretion and cytokine responses in rat macrophages stimulated with lipopolysaccharide. Endocrinology 2005; 146(3): 1321-1327.
68. Permana PA, Menge C, Reaven PD. Macrophage-secreted factors induce adipocyte inflammation and insulin resistance. Biochem Bipphyss Res Commun 2006; 341: 507-514.
69. Chao J, Kato K, Zhang JJ, Dobrzynski E, Wang C, Agata J, et al. Human adrenomedullin gene delivery protects against cardiovascular remodelling and renal injury. Peptides 2001; 22: 1731-1737.
70. Shimosawa T, Ogihara T, Matsuo H, Asano T, Ando K, Fujita T. Deficiency of adrenomedullin induces insulin resistance by increasing oxidative stress. Hypertension 2003; 41: 1080-1085.
71. Molina JM, Cooper GJ, Leighton B, Olefsky JM. Induction of insulin resistance in vivo by amylin and calcitonin gene-related peptide. Diabetes 1990; 39: 260-265.
72. Abaffy T, Cooper GJ. GSK3 involvement in amylin signaling in isolated rat soleus muscle. Peptides 2004; 25: 2119-2125.
73. Marinoni E, Di Iorio R, Villaccio B, Vellucci O, Di Nett T, Sessa M, et al. Adrnomedullin inhuman male reproductive system. Eur J Obstet Gynecol Reprod Biol 2005; 122: 195-198.
74. Li YY, Hwang ISS, O WS, Tang F. Adrenomedullin peptide: Gene expression of adrenomedullin, its receptors and receptor activity modifying proteins, and receptor binding in rat tests-action on testosterone secretion. Biol Reprod 2006; 75: 183-188.
75. Chan YF, O WS, Tang F. Adrenomedullin in the rat testis. I: Its production, actions on testosterone secretion, regulation by human chorionic gonadotropin, and its interaction with endothelin 1 in the Leydig cell. Biol Reprod 2008; 78: 773-779.
76. Chan YF, Tang F, O WS. Adrenomedullin in the rat testis. II: Its production, actions on inhibin secretion, regulation by folliclestimulating hormone, and its interaction with endothelin 1 in the Sertoli cell. Biol Reprod 2008; 78: 780-785.
77. Rossi F, Guerrini L, Pasimeni G, Markouizou A, Fabbrini A, Santiemma V. Testicular peritubular myoid cells are a target for adrenomedullin. Arch Androl 2000; 44: 103-104.
78. Santiemma V, Rossi F, Guerrini L, Markouizou A, Pasimeni G, Palleschi S, et al. Adrenomedullin inhibits the contraction of cultured rat testicular peritubular myoid cells induced by endothelin-1. Biol Reprod 2001; 64: 619-624.
79. Asada Y, Hara S, Marutsuka K, Kitamura K, Tsuji T, Sakata J, et al. Novel distribution of adrenomedullin-immunoreactive cells in human tissues. Histochem Cell Biol 1999; 112: 185-191.
80. Hwang IS, Autelitano DJ, Wong PY, Leung GP, Tang F. Coexpression of adrenomedullin and adrenomedullin receptors in rat epididymis: Distinct physiological actions on anion transport. Biol Reprod 2003; 68: 2005-2012.
81. Jimenez N, Calvo A, Martinez A, Rosell D, Cuttitta F, Montuenga LM. Expression of adrenomedullin and proadrenomedullin Nterminal 20 peptide in human and rat prostate. J Histochem Cytochem 1999; 47: 1167-1178.
82. Pewitt EB, Haleem R, Wang Z. Adrenomedullin gene is abundantly expressed and directly regulated by androgen in the rat ventral prostate. Endocrinology 1999; 140: 2382-2316.
83. Ventura S, Lau WA, Buljubasich S, Pennefather JN. Calcitonin gene-related peptide (CGRP) inhibits contractions of the prostatic stroma of the rat but not the guinea-pig. Regul Pept 2000; 91: 63-73.
84. Shibata Y, Kashiwagi B, Arai S, Magari T, Suzuki K, Honma S. Participation of adrenomedullin and its relation with vascular endothelial growth factor in androgen regulation of prostatic blood flow in vivo. Urology 2006; 68: 1127-31.
85. Li YY, O WS, Tang F. Effect of aging on the expression of adrenomedullin and its receptor component proteins in the male reproductive system of the rat. J Gerontol 2007; 62: 1346-51.
86. Marinoni E, Vellucci O, Letzia C, Sessa M, Moscarini M, Di Iorio R. The level of adrenomedullin immunoreactivity in seminal fluid is higher in oligozoosspermic subjects and correlates with semen biochemical parameters. Eur J Obste Gynecol Reprod Biol 2007; 131: 169-175.
87. Nishimatsu H, Hirata Y, Hayakawa H, Nagata D, Satonaka H, Suzuki E, et al. Effects of intracavernous administration of adrenomedullin on erectile function in rats. Peptides 2001; 22: 1913-1918.
88. Moriyama T, Otani T, Maruo T. Expression of adrenomedullin by human granulosagranulose lutein cells and its effect on progesterone production. Eur J Endocrinol 2000; 142: 671-676.
89. Abe K, Minegishi T, Ibuki Y, Kojima M, Kangawa K. Expression of adrenomedullin in the human corpus luteum. Fertil Steril 2000; 74: 141-145.
90. Marinoni E, Di Iorio R, Letizia L, Lucchini C. Alo P, Cosmi EV. Changes in plasma adrenomedullin levels during the menstrual cycle. Regul Pept 2000; 87: 15-18.
91. Cameron VA, Fleming AM. Novel sites of adrenomedullin gene expression in mouse and rat tissues. Endocrinology 1998; 139: 2253-2264.
92. Li YY, Li L, Hwang ISS, Tang F, O WS. Coexpression of adrenomedullin and its receptors in the reproductive system of the rat: Effects on steroid secretion in the ovary. Biol Reprod 2008; 79: 200-208.
93. Abe K, Minegishi T, Tano M, Hirakwa T, Tsuchiya M, Kangawa K, et al. Expression and effect of adrenomedullin on rat granulosa cell. Endocrinology 1998; 139: 5263-5266.
94. Michishita M, Minegishi T, Abe K, Kangawa K, Kojima M, Ibuki Y. Expression of adrenomedullin in the endometrium of the human uterus. Obstet Gynecol 1999; 93: 66-70.
95. Laoag-Fernandez JB, Otani T, Maruo T. Adrenomedullin expression in the human endometrium. Endocrine 2000; 12: 15-19.
96. Nikitenko LL, MacKenzie IZ, Rees MC, Bicknell R. Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium. Mol Hum Reprod 2000; 6: 811-819.
97. Zhao Y, Hague S, Manek S, Zhang LL, Bicknell R, Rees MC. PCR display identifies tamoxifen induction of the novel angiogenic factor adrenomedullin by a non estrogenic mechanism in the human endometrium. Oncogen 1998; 16: 409-415.
98. Cameron VA, Autelitano DJ, Evan JJ, Ellmers LJ, Espier EA, Nicholls MG, et al. Adrenomedullin expression in rat uterus is correlated with plasma estradiol. Am J Physiol Endocrinol Metab 2002; 282: E139-E146.
99. Makino I, Shaibata K, Makino Y, Kangawa K, Kawarabayahsi T. Adrenomedullin attenuates the hypertension in hypertensive pregnant rats induced by N(G)-nitro-L-arginine methy ester. Eur J Pharmacol 1999; 385: 129-136.
100. Upton PD, Austin C, Taylor GM, Nandha KA, Clark AJL, Ghatteie MA, et al. Expression of adrenomedullin (AM) and its binding sites in the rat uterus: Increased number of binding sites and ADM messenger ribonucleic acid in 20-day pregnant rats compared with nonpregnant rats. Endocrinology 1997; 138: 2508-2514.
101. Yanaita Y, Yamamoto R, Sugano T, Kobayshi H, Uezono Y, Yokoo H, et al. Adrenomedullin inhibits spontaneous and bradykinininduced but not oxytocin-or prostaglandin F2a-incuded periodic contraction of rat uterus. Brit J Pharmacol 2000; 130: 1727-1730.
102. Fazeli A, Affara NA, Hubank M, Holt WV. Sperm-induced modification of the oviductal gene expression profile after natural insemination in mice. Biol Reprod 2004; 71: 60-65.
103. Di Iorio R, Marinoni E, Scavo D, Letizia C, Cosmi EV. Adrenomedullin in pregnancy. Lancet 1997; 349: 328.
104. Jerat S, Kaufman S. Effect of pregnancy and steroid hormones on plasma adrenomedullin levels in theint eh rat. Can J Physiol Pharmacol 1998; 76: 463-466.
105. Kanenishi K, Kuwabara H, Ueno M, Sato C, Sakamoto H, Hata T. Change of adrenomedullin concentrations in plasma and amniotic fluid, and human placental adrenomedullin expression with advancing gestation. Placenta 2002; 22: 244-250.
106. Apodaca CC, Moore KH, Rossignol TM, Pierce B, Matej LA, Hume RF, Jr, et al. Localization of messenger ribonucleic acid for adrenomedullin and adrenomedullin receptor in the human placenta in normal pregnancies and pregnancies complicated by oligohydramnios. Am J Obstet Gynecol 2000; 183: 1213-1219.
107. Thota C, Gangula PR, Dong YL, Yallampalli C. Changes in the expression of calcitonin receptor-like receptor, receptor activitymodifying protein (RAMP) 1, RAMP2, and RAMP3 in rat uterus during pregnancy, labor, and by steroid hormone treatment. Biol Reprod 2003; 69: 1432-1437.
108. Zhang X, Green KE, Yallampalli C, Dong YL. Adrenomedullin enhances invasion by trophoblast cell lines. Biol Reprod 2005; 73: 619-626.
109. Wilson C, Nikitenko LLl, Sargent IL, Rees MC. Adrenomedullin: Multiple functions in human pregnancy. Angiogenesis 2004; 7: 203-212.
110. Penchalaneni J, Wimalawansa SJ, Yallampalli C. Adrenomeullin antagonist treatment during early gestation in rats causes fetoplacental growth restriction through apoptosis. Biol Reprod 2004; 71: 1475-1483.
111. Witlin AD, Li ZY, Wimalawansa SJ, Grady JJ, Grafe MR, Yallampalli C. Placental and fetal growth and development in late rat gestation is dependent on adrenomedullin. Biol Reprod 2002; 67: 1025-1031.
112. Al-Ghafra A, Gude NM, Brennecke SP, King RG. Labourassociated changes in adrenomedullin content in human placenta and fetal membrane. Clin Sci 2003; 105: 419-423.
113. Jougasaki M, Wei CM, McKinley LJ, Burnett JC Jr. Elevation of circulating and ventricular adrenomedullin in human congestive heart failure. Circulation 1995; 92: 286-289.
114. Kobayashi K, Kitamura K, Hirayama N, Date H, Kashiwagi T, Ikushima I, et al. Increased plasma adrenomedullin in acute myocardial infarction. Am Heart J 1996; 131(4): 676-680.
115. Ishimitsu T, Nishikimi T, Saito Y, Kitamura K, Eto T, Kangawa K, et al. Plasma levels of adrenomedullin, a newly identified hypotensive peptide, in patients with hypertension and renal failure. J Clin Invest 1994; 94: 2158-2161.
116. Cheung B, Leung R. Elevated plasma levels of human adrenomedullin in cardiovascular, respiratory, hepatic and renal disorders. Clin Sci 1997; 92: 59-62.
117. Hayashi M, Shimosawa T, Isska M, Yamada S, Fujita R, Fujita T. Plasma adrenomedullin in diabetes. Lancet 1997; 350: 1449-1450.
118. Kikumoto K, Kubo A, Hayashi Y, Minamino N, Inoue S, Dohi K, et al. Increased plasma concentration of adrenomedullin in patients with subarachnoid hemorrhage. Anesth Analg 1998; 87: 859-863.
119. Hirata Y, Mitaka C, Sato K, Nagura T, Tsunoda Y, Amaha K, et al. Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis. J Clin Endocrinol Metab 1996; 81: 1449-1453.
120. Yu CM, Cheung BM, Leung R, Wang Q, Lai WH, Lau CP. Increase in plasma adrenomedullin in patients with heart failure characterised by diastolic dysfunction. Heart 2001; 86(2): 155-160.
121. Washimine H, Yamamoyo Y, Kitamura K, Tanaka M, Ichiki Y, Kangawa K, et al. Plasma concentration of human adrenomedullin in patients on hemodialysis. Clin Nephrol 1995; 44: 389-393.
122. Cheung BMY, Li CYY, Wong LYF. Adrenomedullin: Its role in the cardiovascular system. Seminars Vasc Med 2004; 4(2): 129-134.
123. Kubo A, Minamino N, Isumi Y, Kangawa K, Dohi K, Matsuo H. Adrenomedullin production is correlated with differentiation in human leukemia cell lines and peripheral blood monocytes. FEBS Lett 1998; 426(2): 233-237.
124. Kubo A, Minamino N, Isumi Y, Katafuchi T, Kangawa K, Dohi K, et al. Production of adrenomedullin in macrophage cell line and peritoneal macrophage. J Biol Chem 1998; 273(27): 16730-1678.
125. Isumi Y, Minamino N, Kubo A, Nishimoto N, Yoshizaki K, Yoshioka M, et al. Adrenomedullin stimulates interleukin-6 production in Swiss 3T3 cells. Biochem Biophys Res Commun 1998; 244(2): 325-331.
126. Wong LYF, Leung RYH, Ong KL, Cheung BMY. Up-regulation of Interleukin-10 by Adrenomedullin In Rat Alveolar Macrophage and Human THP-1 Monocytic Cell Lines: Role of the p38- mitogen-activated protein kinase and protein tyrosine kinases presented at the British Pharmacological Society Winter Meeting 2008. Proceedings of the British Pharmacological Society, available at http://www.pa2online.org/abstracts/Vol6Issue4abst125P.pdf (Accessed on: Novermber 8, 2011).
127. Cheung BMY, Lau CS, Leung RYH, Tong KK, Kumana CR. Plasma adrenomedullin in systemic lupus erythematosus. Rheumatology 2000; 39: 804-805.
128. Mak A, Cheung BMY, Mok CC, Leung R, Lau CS. Adrenomedullin-a potential disease activity marker and suppressor of nephritis activity in systemic lupus erythematosus. Rheumatology 2006; 45(10): 1266-1272.
129. Mok MY, Cheung BM, Lo Y, Leung RY, Wong WS, Lau CS. Elevated plasma adrenomedullin and vascular manifestations in patients with systemic sclerosis. J Rheumatol 2007; 34(11): 2224-2229.
130. Martinez A, Miller MJ, Unsworth EJ, Siegfried JM, Cuttitta F. Expression of adrenomedullin in normal human lung and in pulmonary tumours. Endocrinology 1995; 4099-105.
131. Cheung BMY, Tsang KWT, Leung RYH, Chan LY, Kumana CR. Plasma adrenomedullin level is markedly elevated in bronchiectasis. B J Clin Pharmacol 2000; CPT 2000 (Suppl: 14).
132. Shindo T, Kurihara H, Maemura K, Kurihara Y, Kuwaki T, Izumida T, et al. Hypotension and resistance to lipopolysaccharideinduced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101(19): 2309-2316.
133. Fernández AP, Serrano J, Tessarollo L, Cuttitta F, Martínez A. Lack of adrenomedullin in the mouse brain results in behavioral changes, anxiety, and lower survival under stress conditions. Proc Natl Acad Sci USA 2008; 105(34): 12581-1256.
134. Cheung BMY, Huang ISS, Li CYY, O WS, Tsang KWT, Leung RYH, et al. Increased adrenomedullin expression in lungs in endotoxaemia. J Endocrinol 2004; 181: 339-345.
135. Wu R, Zhou M, Wang P. Adrenomedullin and adrenomedullin binding protein-1 downregulate TNF-alpha in macrophage cell line and rat Kupffer cells. Regul Pept 2003; 112: 19-26.
136. Yang S, Zhou M, Chaudry IH, Wang P. The role of lipopolysaccharide in stimulating adrenomedullin production during polymicrobial sepsis. Biocehm Biophy Res Acta 2001; 1537: 167-174.
137. Koo DJ, Zhou M, Chaudry IH, Wang P. The role of adrenomedullin in producing differential hemodynamic responses during sepsis. J Surg Res 2001; 95: 207-218.
138. Yang S, Zhou M, Chaudry IH, Wang P. Novel approach to prevent the transition from the hyperdynamic phase to the hypodynamic phase of sepsis: Role of adrenomedullin and adrenomedullin binding protein-1. Ann Surg 2002; 236(5): 625-633.
139. Matsui E, Kitamura K, Yoshida M, Kato J, Asada Y, Sumiyoshi A, Eto T. Biosynthesis and secretion of adrenomedullin and proadrenomedullin N-terminal 20 peptide in a rat model of endotoxin shock. Hypertens Res 2001; 24: 543-549.
140. Li YY, Cheung BMY, Hwang ISS, Wong LYF, Kumana CR, Tang F. Adrenomedullin gene expression and levels in the cardiovascular system after treatment with lipopolysaccharide. Neuropeptides 2005; 39: 73-80.
141. Li YY, Wong YF, Cheung BMY, Hwang ISS, Kumana CR, Tang F. Differential induction of adenomedullin, interleukins and tumour necrosis factor-α by lipoplysaccharide in rat tissues in vivo. Clin Exp Pharmacol Physiol 2005; 32: 1110-1118.
142. Wang P, Yoo P, Zhou M, Cioffi WG, Ba ZF, Chaudry IH. Reduction in vascular responsiveness to adrenomedullin during sepsis. J Surg Res 1999; 85: 59-65.
143. Wu R, Cui X, Dong W, Zhou M, Simms HH, Wang P. Mechanisms responsible for vascular hyporesponsiveness to adrenomedullin after hemorrhage: The central role of adrenomedullin binding protein- 1. Ann Surg 2005; 242(1): 115-123.
144. Cui Y, Ji Y, Wu R, Zhou M, Wang P. Adrenomedullin binding protein-1 is downregulated during polymicrobial sepsis in the rat. Int J Mol Med 2006; 17(5): 925-929.
145. Wu R, Dong W, Zhou M, Cui X, Simms HH, Wang P. A novel approach to maintaining cardiovascular stability after hemorrhagic shock: Beneficial effects of adrenomedullin and its binding protein. Surgery 2005; 137: 200-208.
146. Atkinson JP, Goodship THJ. Complement factor H and the hemolytic uremic syndrome. JEM 2007; 204: 1245-1248.
147. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, et al. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308: 385-389.
148. Edwards AO, Ritter III R, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science 2005; 308: 421-424.
149. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson LM, Gallins P, et al. Complement factor H variant increases the risk of agerelated macular degeneration. Science 2005; 308(5720): 419-421.
150. Kato J, Tsuruda T, Kita T, Kitamura K, Eto T. Adrenomedullin: A protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005; 25: 2480-2487.
151. Katayama T, Nakashima H, Honda Y, Suzuki S, Yano K. Relationship between adrenomedullin and left-ventricular systolic function and mortality in acute myocardial infarction. Angiology 2005; 56(1): 35-42.
152. Nishida H, Horio T, Suzuki Y, Iwashima Y, Kamide K, Kangawa K, et al. Plasma adrenomedullin as an independent predictor of future cardiovascular events in high-risk patients: Comparison with C-reactive protein and adiponectin. Peptides. 2008; 29(4): 599-605.
153. Behnes M, Papassotiriou J, Walter T, Fiedler E, Sauer T, Lang S, et al. Long-term prognostic value of midregional proadrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction. Clin Chem Lab Med 2008; 46(2): 204-211.
154. Khan SQ, O'Brien RJ, Struck J, Quinn P, Morgenthaler N, Squire I, et al. Prognostic value of midregional pro-adrenomedullin in patients with acute myocardial infarction: The LAMP (Leicester Acute Myocardial Infarction Peptide) study. J Am Coll Cardiol 2007; 49(14): 1525-1532.
155. Christ-Crain M, Morgenthaler NG, Struck J, Harbarth S, Bergmann A, Müller B. Mid-regional pro-adrenomedullin as a prognostic marker in sepsis: An observational study. Crit Care 2005; 9(6): R816-R824.
156. Allaker RP, Grosvenor PW, McAnerney DC, Sheehan BE, Srikanta BH, Pell K, et al. Mechanisms of adrenomedullin antimicrobial action. Peptides 2006; 27(4): 661-666.
157. Hamid SA, Baxter GF. A critical cytoprotective role of endogenous adrenomedullin in acute myocardial infarction. J Mol Cell Cardiol 2006; 41(2): 360-363.
158. Dackor R, Caron K. Mice heterozygous for adrenomedullin exhibit a more extreme inflammatory response to endotoxin-induced septic shock. Peptides 2007; 28(11): 2164-2170.
159. Shindo T, Kurihara H, Maemura K, Kurihara Y, Kuwaki T, Izumida T, et al. Hypotension and resistance to lipopolysaccharideinduced shock in transgenic mice overexpressing adrenomedullin in their vasculature. Circulation 2000; 101: 2309-2316.
160. Wei X, Zhao C, Jiang J, Li J, Xiao X, Wang DW. Adrenomedullin gene delivery alleviates hypertension and its secondary injuries of cardiovascular system. Hum Gene Ther 2005; 16(3): 372-380.
161. Cutitta, F., Martinez, A., Miller, M.J., Unsworh, E.J., Hook, W., Walsh, T., Gray, K., Macri, C. Adrenomedullin peptides. US6320022 (2001).
162. Cutitta, F., Martinez, A., Miller, M.J., Unsworth, E.J., Hook, W.A., Walsh, T., Gray, K., Macri, C. Functional role of adrenomedullin (Am) and the gene related product (PAMP) in human pathology and physiology. US20100021469 (2010).
163. Cutitta, F., Elsasser, T.H., Martinez, A., Pio, R. Determination of am-binding proteins and the association of adrenomedullin (Am) therewit. US20100098703 (2010).
164. Cutitta, F., Martinez, A., Hook, W. Functional role of adrenomedullin (AM) and the gene related product (PAMP) in human pathology. US7939639 (2011).
165. Mimura, T., Kohama, Y., Okabe, M., Tsujikawa, K., Noda, Y. Radioactive iodine labeled insulin-like growth factor I. JP4282399 (1992).
166. Urdea, M.S., McKenna, M.P., Arensdorf, P.A. Diabetes related biomarkers and methods of use thereof. US20090012716 (2009).
167. Ng, L.L., Bergmann, A., Struck, J., Morgenthaler, N., Papassotiriou, J. Methods of diagnosis and risk stratification of adverse events in post myocardial infarction patients using proadrenomedullin. US20080213746 (2008).
168. Bergmann, A., Struck, J., Melander, O., Newton-Cheh, C., Wang, T.J. Biomarker for the prediction of first adverse events. WO2010040564 (2010).
169. Bergmann, A., Struck, J. Determination of midregional proadrenomedullin partial region in biological fluid for diagnostic purposes, and immunoassay for carrying out this determination.JP2010210644 (2010).
170. Bergmann, A., Struck, J., Morgenthaler, N.G. Methods for the diagnosis and treatment of critically ill patients with endothelin, endothelin agonists and adrenomedullin antagonists. US20090191220 (2009).
171. Troughton RW, Lewis LK, Yandle TG, Richards AM, Nicholls MG. Hemodynamic, hormone, and urinary effects of adrenomedullin infusion in essential hypertension. Hypertension 2000; 36(4): 588-593.
172. Nishikimi T, Yoshihara F, Horinaka S, Kobayashi N, Mori Y, Tadokoro K, et al. Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to heart failure in rats. Hypertension 2003; 42(5): 1034-1041.
173. Niu P, Shindo T, Iwata H, Ebihara A, Suematsu Y, Zhang Y, et al. Accelerated cardiac hypertrophy and renal damage induced by angiotensin II in adrenomedullin knockout mice. Hypertens Res 2003; 26(9): 731-736.
174. Chao J, Chao L. The role of adrenomedullin in cardiovascular and renal function. Drug News Perspect 2002; 15(8): 511-518.
175. Hojo Y, Ikeda U, Mizuno O, Katsuki TA, Shimada K. Adrenomedullin expression in coronary circulation after stent implantation as a prognostic factor for restenosis. Int J Cardiovasc Intervent 2003; 5(4): 190-4.
176. Agata J, Zhang JJ, Chao J, Chao L. Adrenomedullin gene delivery inhibits neointima formation in rat artery after balloon angioplasty. Regul Pept 2003; 15; 112: 115-120.
177. Nagaya, N., Miyatake, K., Kangawa, K., Kataoka, M. Fat-derived progenitor cell and use thereof. EP1878789 (2008).
178. Nagaya, N., Miyatake, K., Kangawa, K., Murakami, S. Method of regenerating or repairing damaged tissue by using adrenomedulin. EP1878436 (2008).
179. Wang, P. Adrenomedullin and adrenomedullin binding protein for ischemia/reperfusion treatment. US20080051316 (2008).
180. Cornish, J., Reid, I. R., Cooper, G. J. S. Adrenomedullin agonists. US7314856 (2008).
181. Iwase T, Nagaya N, Fujii T, Itoh T, Ishibashi-Ueda H, Yamagishi M, et al. Adrenomedullin enhances angiogenic potency of bone marrow transplantation in a rat model of hindlimb ischemia. Circulation 2005; 111(3): 356-362.
182. Iimuro S, Shindo T, Moriyama N, Amaki T, Niu P, Takeda N, Iwata H, et al. Angiogenic effects of adrenomedullin in ischemia and tumor growth. Circ Res 2004; 95(4): 415-423.
183. Hay DL, Walker CS, Poyner DR. Adrenomedullin and calcitonin gene-related peptide receptors in endocrine-related cancers: Opportunities and challenges. Endocr Relat Cancer 2010; 18(1): C1-C14.
184. Ishikawa T, Chen J, Wang J, Okada F, Sugiyama T, Kobayashi T, et al. Adrenomedullin antagonist suppresses in vivo growth of human pancreatic cancer cells in SCID mice by suppressing angiogenesis. Oncogene 2003; 22(8): 1238-1242.
185. Robinson SD, Aitken JF, Bailey RJ, Poyner DR, Hay DL. Novel peptide antagonists of adrenomedullin and calcitonin gene-related peptide receptors: Identification, pharmacological characterization, and interactions with position 74 in receptor activity-modifying protein 1/3. J Pharmacol Exp Ther 2009; 331(2): 513-521.
186. Skerry, T.M., Richard, G.O. Therapeutic agent. US20110195076 (2011).
187. Ouafik, L., Mabrouk, K., Kaafarany, I., Martin, P.-M. Antibodies binding to adrenomedullin receptors and uses thereof as drugs. EP2318440 (2009).